drugset / Trial / NCT03016520

Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers

NCT03016520 ↗

Phase 1 Unknown 28 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study to Compare the safety and pharmacokinetics of DWJ1392 and DWC20164 in healthy male volunteers.

Timeline

Start
2017-01-09
Primary completion
2017-01-26
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC20164 Unknown — —
Subject DWJ1392 Unknown — —

Indications

No indication recorded.